Steven Cohen Dexcom Inc Call Options Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $6.4 Million - $11.6 Million	100,000 New	100,000 $6.7 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $7.77 Million - $9.53 Million	68,000 Added 566.67%	80,000 $11.1 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $905,879 - $1.49 Million	12,000 New	12,000 $1.49 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $1.12 Million - $1.31 Million	10,000 New	10,000 $1.29 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $982,450 - $1.34 Million	-35,000 Reduced 41.18%	50,000 $5.96 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $945,199 - $1.31 Million	85,000	85,000 $4.88 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.